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Calcium pulse additions to isolated SR membranes can cause a reversible efflux of calcium. The threshold 
level of calcium loading at which calcium efflux occurs is lower for SR membranes isolated from malignant 
hyperthermia susceptible (MHS) swine. Dantrolene, a unique muscle relaxant, had no effect on threshold 
calcium load, amounts and rates of calcium release from SR isolated from control and MHS skeletal 
muscle. It is concluded that the putative calcium channel through which this calcium pulse-induced calcium 
release mechanism occurs is not affected by dantrolene under these experimental conditions. 
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1. INTRODUCTION 
A recent report [l] provided indirect evidence to 
conclude that dantrolene inhibited halothane- 
induced calcium release from SR isolated from 
skeletal muscle of pigs genetically predisposed to 
malignant hyperthermia. We have also examined 
the calcium-induced calcium release from a 
putative calcium channel in a heavy SR fraction 
from rabbit muscle [2]. Further, we have previous- 
ly reported an abnormality of calcium efflux from 
this calcium channel in the SR from skeletal muscle 
of genetically predisposed malignant hyperthermia 
susceptible (MHS) pigs [3]. The basis for this ab- 
normality lies primarily in the lower calcium 
threshold for calcium pulse-induced calcium 
release [3]. Here we have measured the effect of 
dantrolene on this mechanism in SR from control 
and MHS porcine skeletal muscle. 
2. MATERIALS AND METHODS 
Three purebred MH-susceptible Poland China 
pigs and 3 control pigs were used to obtain gracilis 
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muscle biopsies. The control pigs were 2 purebred 
Poland China littermates (unrelated to MH pigs) 
and one cross-bred pig. Each animal’s susceptibili- 
ty to MH was assessed by in vitro muscle contrac- 
ture testing [4] and by a thorough anesthetic 
challenge [S]. The MH-susceptible animals were 
phenotype H [5] and the controls were phenotype 
N (negatives). Gracilis muscle was obtained while 
each animal was anesthetized with thiopental and 
spontaneously breathing 100% oxygen through an 
orotracheal tube. Muscle fascicles were excised and 
contracture tested as in [4]. The remainder of the 
gracilis muscle, -30 g, was surgically removed in 
bulk, placed on an ice block and minced for 
homogenization and centrifugation as in [3]. Only 
a heavy SR fraction (8-12000 + g) was used in this 
study. Calcium release from the SR was induced by 
the calcium pulse technique in [2,3]. The threshold 
for calcium release is defined as the cumulative 
calcium pulses (2 ,uM each) at which calcium efflux 
occurred. In addition to threshold, rate and 
amount of calcium released were measured. 
Calcium uptake and release by the SR was 
measured in a dual wavelength (650-700 
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nanometers) spectrophotometer utilizing arsenazo 
III as a calcium indicator. The experimental condi- 
tions for calcium pulse-induced calcium release in 
the cuvette were KCI, 150 mM; histidine, 20 mM 
(pH 6.8); NaNs, 5 mM; arsenazo III, 16pM; Mg- 
ATP, 1 mM and SR, 0.5 mg/ml. The total cuvette 
volume of 1 ml was maintained at 30°C. Calcium 
was added as 2 ,uM pulses (0.5 ,ul) as in [3]. Dan- 
trolene was dissolved in tetrahydrofurfuryl alcohol 
(THFA) at a stock concentration of 0.1 M. Serial 
dilutions of stock dantrolene in THFA were made 
such that a 0.5 ,J addition to the cuvette would 
provide a final concentration of 6.25, 12.5, 25, or 
50pM dantrolene. For solvent control, 0.5 yl 
THFA was tested. Dantrolene or THFA was added 
to the cuvette immediately (-30 s) before calcium 
pulse additions were initiated. 
3. RESULTS 
Gracilis skeletal muscle of the MHS pigs 
responded in a characteristically abnormal manner 
to the in vitro application of halothane and caf- 
feine [4,5]. An isometric contracture response to 
3% halothane (2 = 1.15 g) is characteristic of a 
phenotype H genetic predisposition [5] (fig.1). In 
contrast, muscle from control pigs had no contrac- 
ture response to 3% halothane, but instead only a 
potentiation of the electrically evoked twitch was 
observed (fig.1). Similarly, MHS pig muscle had 
abnormal sensitivity to the contracture producing 
effect of caffeine applied in vitro. The threshold 
caffeine concentration for contracture was 2 mM 
for MHS muscle and 8 mM for controls (fig.2). 
The average caffeine concentration producing 1 g 
isometric contracture was calculated from the 
dose-response curve and this value was 3.7 + 1.7 
for MHS and 11.9 + 2.3 for controls. 
The heavy SR fraction isolated from the MHS 
pig muscle was also abnormally different from the 
heavy SR isolated from control muscle. As 
reported [3], the threshold for calcium pulse-in- 
duced calcium release is lower for SR from MHS 
(i = 11.3 + 8.3 nmol Ca/mg SR) than that for con- 
trols (x = 86.2 & 18 nmol Ca/mg SR). The amount 
of calcium released was greater for controls than 
for MHS SR fractions wherease no difference was 
observed for rate of Ca2+ release between the two 
types of SR (table 1). 
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Fig. 1. The effect of 3% halothane on control and 
malignant hyperthermia susceptible skeletal muscle in 
vitro. Halothane 3% (v/v) was initiated at arrows. In 
upper panel, control muscle responded with twitch 
potentiation while malignant hyperthermia muscle 
(lower panel) has a contracture response. 
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Fig.2. Contracture response of control (upper panel) and 
malignant hyperthermia susceptible (lower panel) pig 
skeletal muscle to caffeine. Contracture, upward shift in 
baseline, is initiated at 8 mM caffeine in control muscle 
and at 2 mM caffeine in malignant hyperthermia 
muscle. 
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Effect of dantrolene on calcium pulse-induced Ca*+ release from MH and control sarcoplasmic reticulum 
Control THFA= Dantrolene hM) 
6.25 12.5 25 50 
Threshold Cb 86.2 + 18 80.8 + 18 81.2 + 20 75.4 + 15 80.0 f 23 80.7 f 21 
nmol Ca*+/mg SR MHC 17.3 k 8 14.0 k 9 12.7 f 11 14.0 + 13 13.3 + lo 11.3 f 9 
Amount C 13.0 f 12 12.3 f 13 17.1 + 16 11.3 + 11 12.2 + 12 12.5 f 12 
nmol Ca*+/mg SR MH 1.3 + 0.4 2.4 f 1.7 2.6 + 1.5 2.6 f 1.7 2.4 f 1.1 2.1 + 1.1 
Rate C 1.5 * 2 1.97 + 2 2.99 + 4 1.87 f 2 2.0 f 2 2.18k 3 
nmol Ca*+ .SC’ . mg-’ MH 1.19* 0.5 1.47 * 1.0 1.48 f 0.8 2.32 f 2 1.82 f 0.9 l.lO+ 0.6 
a THFA is 0.5 pl of dantrolene solvent (tetrahydrofurfuryl alcohol), the volume for each concentration of dantrolene 
studied 
b C, HSR preparations from 3 control pig muscle 
’ MH, HSR preparations from 3 MH-susceptible pig muscle 
Each value is the mean + SD 
The solvent for dantrolene, THFA at a concen- 
tration of 5 PM slightly decreased threshold and 
increased rate and amount of Ca2+ release from 
MH-SR (table 1). Dantrolene, at concentrations 
ranging from 6.25 to 50pM, did not significantly 
alter the threshold, rate or amount of calcium 
release observed for the THFA-treated MH-SR 
membranes (table 1). Likewise, dantrolene did not 
significantly change the threshold, rate and 
amount for calcium pulse-induced calcium release 
from the values observed in THFA-treated control 
SR membranes (table 1). 
4. DISCUSSION 
Malignant hyperthermia is a catastrophic, 
hypermetabolic syndrome occurring in genetically 
predisposed man and animals [6]. It is usually 
associated with the clinical use of halogenated 
anesthetic agents and the muscle relaxant suc- 
cinylcholine. The primary defect appears to exist in 
skeletal muscle and an idiopathic increase in 
myoplasmic Ca2+ is postulated as the primary 
etiologic event. The abnormal in vitro contracture 
response of MHS skeletal muscle to caffeine and to 
halothane demonstrate the myogenic basis for 
MH. Although the association between caffeine’s 
contracture producing effects on skeletal muscle 
and its effects on calcium uptake and release by the 
SR have been recognized for some time [7], it is on- 
ly recently that a pharmacogenetic defect has been 
described for SR isolated from MHS skeletal mus- 
cle [3]. In that study [3], a defective calcium release 
mechanism was identified and the putative calcium 
channel for these events had abnormal sensitivity 
to caffeine. 
Here, dantrolene, a unique, directly acting mus- 
cle relaxant, had no observable effect on the 
threshold for calcium pulse-induced calcium 
release nor did it effect the rate and amounts of 
calcium released. This lack of dantrolene effect 
was the same for calcium release mechanisms in 
both control and MH-SR fractions. Dantrolene is 
the therapeutic and prophylactic agent for MH and 
yet it does not block the abnormal calcium pulse- 
induced calcium release from the MH-SR mem- 
brane. Several explanations can be given for this 
apparent discrepancy. It has been proposed that 
one or more steps in the electromechanical coupl- 
ing pathway of MH skeletal muscle may be defec- 
tive [8,9]. Dantrolene may be acting at some site in 
the electromechanical coupling pathway that is 
either proximal or distal to the abnormal calcium 
channel and thereby blocking the abnormal 
calcium release. It is also possible that more than 
one defective site exists in MH skeletal muscle and 
the abnormal calcium efflux represents only one 
defect. Although several sites of action for dan- 
trolene on skeletal muscle have been suggested 
[8,10], the exact site(s) remain(s) unknown. A 
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previous study showed that 20/cM dantrolene 
decreased the amount of calcium released by 
halothane effects on a heavy SR fraction 111. This 
study did not describe the solvent used for the 
poorly water-soluble dantrolene nor did it state if 
the SR studied was from control or MH pig mus- 
cle. A number of serious inconsistencies in this 
report [l] draws concern. For example, Mg con- 
centrations varied from 0.5 to 10 mM in the ex- 
periments reported without Mg effects being 
studied and in fig.4 of that study it states that 
O-40 ,eM dantrolene was studied and only one 
dantrolene dose is shown. These experimental in- 
consistencies make it difficult to draw conclusions 
from this previous investigation. 
Here, no dantrolene effect on calcium pulse- 
induced calcium release was observed. Since this 
mechanism appears to represent one possible 
defect in the SR membrane from MHS skeletal 
muscle, the exact site of action of dantrolene to 
block muscle contraction and the MH syndrome is 
yet to be determined. 
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